APA (7th ed.) Citation

Ataka, T., Kimura, N., Kaneko, N., Masuda, T., Takeuchi, Y., Yabuuchi, K., . . . Matsubara, E. (2024). Plasma amyloid beta biomarkers predict amyloid positivity and longitudinal clinical progression in mild cognitive impairment. Wiley. https://doi.org/10.1002/trc2.70008

Chicago Style (17th ed.) Citation

Ataka, Takuya, et al. Plasma Amyloid Beta Biomarkers Predict Amyloid Positivity and Longitudinal Clinical Progression in Mild Cognitive Impairment. Wiley, 2024. https://doi.org/10.1002/trc2.70008.

MLA (9th ed.) Citation

Ataka, Takuya, et al. Plasma Amyloid Beta Biomarkers Predict Amyloid Positivity and Longitudinal Clinical Progression in Mild Cognitive Impairment. Wiley, 2024. https://doi.org/10.1002/trc2.70008.